[Form 4] REGAL REXNORD CORP Insider Trading Activity

Rhea-AI Filing Summary

Regal Rexnord (RRX) insider activity: The company’s EVP and CFO reported an acquisition of 24.032 shares of common stock on 10/14/2025 at $143.14 per share. The filing notes these were additional restricted stock units credited via dividend-equivalent reinvestment and subject to the same vesting terms as the underlying RSU awards.

Following the transaction, the reporting person beneficially owned 41,835.747 shares directly. The filing also lists multiple outstanding stock appreciation rights (SARs) covering shares of common stock with exercise prices ranging from $74.04 to $168.47 and expirations between 05/10/2027 and 02/23/2034, with vesting schedules disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rehard Robert

(Last) (First) (Middle)

111 WEST MICHIGAN STREET

(Street)

MILWAUKEE WI 53203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGAL REXNORD CORP [ RRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO*

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/14/2025		A		24.032	A(1)	$143.14	41,835.747	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$76.99							05/10/2019(2)	05/10/2027	Common Stock	2,164		2,164	D
Stock Appreciation Rights	$74.04							05/09/2020(2)	05/09/2028	Common Stock	7,730		7,730	D
Stock Appreciation Rights	$78.05							05/08/2021(2)	05/08/2029	Common Stock	15,382		15,382	D
Stock Appreciation Rights	$84.39							02/18/2021(3)	02/18/2030	Common Stock	12,340		12,340	D
Stock Appreciation Rights	$133.77							02/23/2022(3)	02/23/2031	Common Stock	9,276		9,276	D
Stock Appreciation Rights	$151.27							02/23/2023(3)	02/23/2032	Common Stock	8,292		8,292	D
Stock Appreciation Rights	$154.2							02/23/2024(3)	02/23/2033	Common Stock	9,456		9,456	D
Stock Appreciation Rights	$168.47							02/23/2025(3)	02/23/2034	Common Stock	7,657		7,657	D

Explanation of Responses:

1. Represents additional restricted stock units credited to the reporting person under the dividend equivalent reinvestment provision of the reporting person's outstanding restricted stock unit awards as a result of a quarterly dividend payment. The additional restricted stock units resulting from the dividend equivalent reinvestment are subject to the same terms and conditions, including vesting, as the outstanding restricted stock unit awards to which they are attributable.

2. The Stock Appreciation Rights vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.

3. The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.

Remarks:

*Executive Vice President and Chief Financial Officer

	/s/ Hugo Dubovoy Jr., as Power of Attorney	10/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did RRX’s CFO report on Form 4?

An acquisition of 24.032 shares credited as dividend-equivalent RSUs on 10/14/2025 at $143.14 per share.

How many RRX shares does the reporting person now own?

Following the transaction, beneficial ownership is 41,835.747 shares, held directly.

What is the nature of the 24.032 additional shares?

They are restricted stock units credited under the dividend-equivalent reinvestment provision and carry the same vesting terms as the related RSU awards.

What derivative awards are disclosed for RRX’s CFO?

Multiple stock appreciation rights (SARs) with exercise prices from $74.04 to $168.47 and expirations between 05/10/2027 and 02/23/2034, with staged vesting.

Can you provide examples of SAR positions?

Examples include 2,164 shares at $76.99 expiring 05/10/2027 and 9,456 shares at $154.20 expiring 02/23/2033.

What is the reporting person’s role at RRX?

The reporting person is the company’s Executive Vice President and Chief Financial Officer.